Evotec
Evotec Strikes Metabolic Disease Research Alliance With Inserm, Lille University Hospital
Evotec will use samples from an ongoing clinical trial of obesity to generate omics data that can provide insights into the etiology of various metabolic diseases.
Evotec Exits Gene Therapy as Part of 'Priority Reset' to Improve Profitability
The "strategic exit" comes amid a challenging start to the year, as the company's revenue declined, and net loss grew in Q1 2024 compared to the year-ago period.
Evotec, Hannover Medical School Partner on Multiomic Autoimmune Disease Patient Database
The German medical school will analyze samples from hundreds of Sjögren's and systemic lupus erythematosus patients in search of new treatment pathways.
Evotec, Indivumed Partner on Colorectal Cancer Drug Discovery
Evotec will access Indivumed's IndivuType multi-omics cancer database to discover and develop new precision therapeutics for colorectal cancer.